Hello, everyone, and how are you today? We are doing just fine, thank you, since a cool breeze and sunny skies are enveloping the Pharmalot campus. One short person has left for work and the other is sleeping in, as is the official mascot. This leaves us to focus on matters at hand, which start with brewing cups of stimulation (butter pecan, for those keeping track) and foraging for items of interest. Speaking of which, here is a new batch. Hope your day goes well and do keep us in mind when something saucy occurs …

A federal judge blocked a Trump administration regulation that requires drug makers to include list prices in ads, STAT writes. The decision, which came just hours before the rule was set to take effect, came after three drug makers sued the administration, arguing the Department of Health and Human Services did not have the authority to require the disclosures and requiring them violated First Amendment rights. While agreeing that HHS overstepped its authority in requiring such disclosures, the judge did not rule on the First Amendment concerns.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy